Corcept Therapeutics | CORT - 净收入



金融业
股票价格
USD
资产
USD 814.88M
现金及等价物
USD 108.74M
销售成本
USD 2.88M
流动资产
USD 426.03M
流动负债
USD 149.19M
债务
USD 6.11M
EBIT
USD -49.6M
EBITDA
USD 4.2M
员工
500
EPS每股收益
USD -0.3
股本和储备
USD 637.99M
销售毛利
USD 162.02M
债务利息支出
USD 814.88M
利息收入
USD 5.42M
市值
USD 9.55B
净收入
USD -31.76M
营业费用
USD 214.5M
营业利润
USD -49.6M
普通股股本
USD 107.33M
PE价格收益
113.58
税前利润
USD 9.91M
销售收入
USD 164.9M
销售和管理费用
USD 128.04M
股票
USD 12.89M
贸易债权人
USD 33.31M
应收帐款人
USD 39.07M


净收入 更改 日
Acadia Pharmaceuticals USD 3.64M 269.93M 2026-03
Alaunos Therapeutics USD -1.01M 153K 2026-03
ANI Pharmaceuticals USD 29.49M 2.86M 2026-03
Ardelyx USD -37.6M 37.2M 2026-03
Aurora Cannabis CAD -71.1M 72.92M 2026-03
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Canopy Growth CAD -157.11M 94.49M 2026-03
Corcept Therapeutics USD -31.76M 56.05M 2026-03
Eli Lilly USD 7.4B 760M 2026-03
Esperion Therapeutics USD 61.83M 93.16M 2025-12
J&J USD 5.24B 119M 2026-03
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Lexicon Pharmaceuticals USD -15.53M 2.76M 2025-12
Merck USD -4.24B 7.2B 2026-03
Nektar Therapeutics USD -36.08M 978K 2025-12
Novartis USD 3.16B 747M 2026-03
Novartis USD 3.16B 747M 2026-03
Omeros USD -32.23M 23.81M 2024-09
Pacira USD 2.92M 1.28M 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Supernus Pharmaceuticals USD -2.29M 1.81M 2026-03
TG Therapeutics USD 19.78M 3.26M 2026-03